Search

everythinglearnresearchcommunity

for

Search:↓

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Estrogen and androgen signals control synaptic changes in rat brains.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Finasteride caused enlarged breast tissue in a 62-year-old man.